Literature DB >> 12540138

Prehospital management of acute tachyarrhythmias.

Corey M Slovis1, Peter J Kudenchuk, Marvin A Wayne, Richard Aghababian, Edgardo J Rivera-Rivera.   

Abstract

Arrhythmias are commonly encountered by emergency medical services (EMS) personnel. The potential seriousness of acute symptomatic arrhythmias necessitates thorough up-to-date training of EMS personnel. The three most common acute tachyarrhythmias, not linked to cardiac arrest, that are observed outside the hospital are paroxysmal supraventricular tachycardia (PSVT), atrial fibrillation with rapid ventricular response (RAF), and perfusing ventricular tachycardia (VT). Ideally, these tachyarrhythmias should be operationally defined in a manner that simplifies, particularly for EMS providers, their diagnosis and treatment. The authors recommend referring to these rhythms as regular narrow-complex tachycardia (presumed PSVT), irregularly irregular narrow-complex tachycardia (presumed RAF), or regular wide-complex tachycardia (presumed VT or aberrantly conducted PSVT). Although the value of treatments such as cardioversion is widely understood, the benefit from others, such as lidocaine, is unclear. Current preferences, recommendations, and concerns regarding the treatment of most arrhythmias outside the hospital reflect the dichotomy that sometimes exists between available evidence and actual practice.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12540138     DOI: 10.1080/10903120390937030

Source DB:  PubMed          Journal:  Prehosp Emerg Care        ISSN: 1090-3127            Impact factor:   3.077


  2 in total

1.  The importance of the mean platelet volume in the diagnosis of supraventricular tachycardia.

Authors:  Tarik Ocak; Alim Erdem; Arif Duran; Ümit Yaşar Tekelioğlu; Serkan Öztürk; Suzi Selim Ayhan; Mehmet Fatih Özlü; Mehmet Yazici
Journal:  Afr Health Sci       Date:  2014-03       Impact factor: 0.927

2.  The importance of the mean platelet volume in the diagnosis of supraventricular tachycardia.

Authors:  T Ocak; A Erdem; A Duran; U Tekelioglu; S Öztürk; S Ayhan; F M Özlü; M Yazici
Journal:  Afr Health Sci       Date:  2013-09       Impact factor: 0.927

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.